Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy

Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CGP was initially developed to enroll patients into...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshii, Yumi, Okazaki, Shunsuke, Takeda, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399872/
https://www.ncbi.nlm.nih.gov/pubmed/34440540
http://dx.doi.org/10.3390/life11080796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399872/
https://www.ncbi.nlm.nih.gov/pubmed/34440540
http://dx.doi.org/10.3390/life11080796

Ejemplares similares